Sanders Opposes America COMPETES Act Over Billions in ‘Corporate Welfare’
Sanders takes on the supposed US competitiveness-boosting COMPETES Act as corporate grifting.
Read more...Sanders takes on the supposed US competitiveness-boosting COMPETES Act as corporate grifting.
Read more...How the growth of a billionaire class is the result of policy choices.
Read more...The IEA last week proposed 10-point plan to curb oil use. Alas, it’s unlikely that current U.S. regulators and political leaders. will provide any more than lip service to these and other long overdue measures.
Read more...Senators introduce right to repair bill. Antitrust litigation will proceed regardless of whether federal or state legislation is enacted anytime soon.
Read more...Firms with political connections, and those owned by large and influential shareholders, benefitted most from allocation of COVID bailout funds.
Read more...The Zients-led Covid response refused to challenge drug company overlords by promoting non-pharmaceutical interventions.
Read more...Experts say institutional biosafety committees are a crucial to ensuring the safety of biomedical research. Critics say they are too opaque.
Read more...It appears Urkainian President Zelensky was not in Kiev on March 15 as widely reported, but in Poland….and presumably still is there.
Read more...Why do so many people who think of themselves as smart have their brains go to mush when the topic is crypto?
Read more...The new Cold War as the gift that keeps giving to America’s arms merchants.
Read more...More on the possiblity of severe blowback from sanctions against Russia in the form of trade disruption.
Read more...The Supreme Court may rule to weaken oversight of Congressional redisctricting.
Read more...India is mulling setting up rupee-ruble payment arrangements, to allow it to trade with Russia in spite of the sanctions regime.
Read more...Sanders calls out baseball oligarchs for major league lockout.
Read more...‘Billionaire CEO shouldn’t get to choose who lives and who dies,’ said one advocacy group after Moderna’s patent announcement.
Read more...